Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage, Neuropathol. Appl. Neurobiol, vol.25, pp.123-133, 1999. ,
HIV-1 protein-mediated amyloidogenesis in rat hippocampal cell cultures, Neurosci. Lett, vol.475, pp.174-178, 2010. ,
Retroviruses and amyotrophic lateral sclerosis, Antiviral Res, vol.99, pp.180-187, 2013. ,
Amyloid beta accumulation in HIV-1-infected brain: the role of the blood brain barrier, IUBMB Life, vol.65, pp.43-49, 2013. ,
Blood-brain barrier integrity, intrathecal immunoactivation and neuronal injury in HIV, Neurol. Neuroimmunol. Neuroinflamm, vol.3, p.300, 2016. ,
Accelerated Tau deposition in the brains of individuals infected with human immunodeficiency virus-1 before and after the advent of highly active anti-retroviral therapy, Acta Neuropathol, vol.111, pp.529-538, 2006. ,
Updated research nosology for HIV-associated neurocognitive disorders, Neurology, vol.69, pp.1789-1799, 2007. ,
Effect of human immunodeficiency virus on bloodbrain barrier integrity and function: an update, Front. Cell. Neurosci, vol.9, p.212, 2015. ,
Synaptic dysfunction in human immunodeficiency virus type-1-positive subjects: inflammation or impaired neuronal plasticity?, J. Intern. Med, vol.273, pp.454-465, 2013. ,
Activated microglia mediate synapse loss and short-term memory deficits in a mouse model of transthyretin-related oculoleptomeningeal amyloidosis, Cell Death Dis, vol.4, 2013. ,
M-and T-tropic HIVs promote apoptosis in rat neurons, J. Neuroimmune Pharmacol, vol.4, pp.150-160, 2009. ,
Clinical and biomarker changes in dominantly inherited Alzheimer's disease, N. Engl. J. Med, vol.367, pp.795-804, 2012. ,
Vascular risk factors, HIV serostatus and cognitive dysfunction in gay and bisexual men, Neurology, vol.73, pp.1292-1299, 2009. ,
Ethanol pre-exposure suppresses HIV-1 glycoprotein 120-induced neuronal degeneration by abrogating endogenous glutamate/Ca 2+ -mediated neurotoxicity, Neuroscience, vol.104, pp.769-781, 2001. ,
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease, Nat. Rev. Neurol, vol.6, pp.131-144, 2010. ,
CSF amyloid ?42 and tau levels correlate with AIDS dementia complex, Neurology, vol.65, pp.1490-1492, 2005. ,
Effects of glucocorticoids in the gp120-induced inhibition of glutamate uptake in hippocampal cultures, Brain Res, vol.972, pp.137-141, 2003. ,
Deregulation of hypothalamic-pituitary-adrenal axis functions in an Alzheimer's disease rat model, Neurobiol. Aging, vol.34, pp.1426-1439, 2013. ,
Blood-derived amyloid-? protein induces Alzheimer's disease pathologies, Mol. Psychiatry, 2017. ,
Apical-to-basolateral transport of amyloid-? peptides through blood-brain barrier cells is mediated by the receptor for advanced glycation end-products and is restricted by P-glycoprotein, J. Alzheimers Dis, vol.22, pp.849-859, 2010. ,
A stable and reproducible human blood-brain barrier model derived from hematopoietic stem cells, PLoS One, vol.9, p.99733, 2014. ,
, , 2017.
, HIV-1 counteracts an innate restriction by amyloid precursor protein resulting in neurodegeneration, Nat. Commun, vol.8, p.1522
A tale of two diseases: aging HIV patients inspire a closer look at Alzheimer's disease, Nat. Med, vol.24, pp.376-377, 2018. ,
Endocrine modulators of necrotic neuron death, Brain Pathol, vol.6, pp.481-491, 1996. ,
A novel point mutation in the ligand-binding domain (LBD) of the human glucocorticoid receptor (hGR) causing generalized glucocorticoid resistance: the importance of the C terminus of hGR LBD in conferring transactivational activity, J. Clin. Endocrinol. Metab, vol.90, pp.3696-3705, 2005. ,
Glucocorticoid receptors recruit the CaMKII?-BDNF-CREB pathways to mediate memory consolidation, Nat. Neurosci, vol.15, pp.1707-1714, 2012. ,
HIV-1 Tat-induced cerebrovascular toxicity is enhanced in mice with amyloid deposits, Neurobiol. Aging, vol.33, pp.1579-1590, 2012. ,
HIV-1 Tat regulates occludin and A? transfer receptor expression in brain endothelial cells via Rho/ROCK signaling pathway, Oxid. Med. Cell. Longev, p.4196572, 2016. ,
Endolysosome involvement in HIV-1 transactivator protein-induced neuronal amyloid beta production, Neurobiol. Aging, vol.34, pp.2370-2378, 2013. ,
Signaling mechanism of HIV-1 gp120 and virion-induced IL-1? release in primary human macrophages, J. Immunol, vol.180, pp.6675-6684, 2008. ,
Neuronal cell death and degeneration through increased nitroxidative stress and tau phosphorylation in HIV-1 transgenic rats, PLoS One, vol.12, 2017. ,
Serum cortisol and DHEA concentrations during HIV infection, Psychoneuroendocrinology, vol.22, issue.97, pp.15-17, 1997. ,
Syndromes of glucocorticoid resistance, Ann. Intern. Med, vol.119, pp.1113-1124, 1993. ,
Hypothalamic-pituitary-adrenal axis in HIV infection and disease, Endocrinol. Metab. Clin. North Am, vol.43, pp.791-806, 2014. ,
HIV-1 transcriptional regulation in the central nervous system and implications for HIV cure research, J. Neurovirol, vol.21, pp.290-300, 2015. ,
Natural oligomers of the amyloid-? protein specifically disrupt cognitive function, Nat. Neurosci, vol.8, pp.79-84, 2005. ,
HIV-associated neurocognitive disorder, Lancet Infect. Dis, vol.13, pp.976-986, 2013. ,
CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease, Neurology, vol.73, pp.1982-1987, 2009. ,
Serum cortisol in HIV-infected patients with and without highly active antiretroviral therapy, AIDS, vol.17, pp.123-126, 2003. ,
Human brain parenchymal microglia express CD14 and CD45 and are productively infected by HIV-1 in HIV-1 encephalitis, Brain Pathol, vol.12, pp.442-455, 2002. ,
Stimulating effect of HIV-1 coat protein gp120 on corticotropinreleasing hormone and arginine vasopressin in the rat hypothalamus: involvement of nitric oxide, Exp. Neurol, vol.166, pp.376-384, 2000. ,
The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights, Mol. Cell. Endocrinol, vol.335, pp.2-13, 2011. ,
Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia, Am. J. Psychiatry, vol.163, pp.2164-2169, 2006. ,
Alzheimer's disease, N. Engl. J. Med, vol.351, pp.56-67, 2004. ,
URL : https://hal.archives-ouvertes.fr/hal-01579097
Variable benefit in neuropsychological function in HIV-infected HAART-treated patients, Neurology, vol.66, pp.1447-1450, 2006. ,
Tat peptides inhibit neprilysin, J. Neurovirol, vol.12, pp.153-160, 2006. ,
Infectious agents and neurodegeneration, Mol. Neurobiol, vol.46, pp.614-638, 2012. ,
Stress and the brain: from adaptation to disease, Nat. Rev. Neurosci, vol.6, pp.463-475, 2005. ,
The coat protein gp120 of HIV-1 inhibits astrocyte uptake of excitatory amino acids via macrophage arachidonic acid, Eur. J. Neurosci, vol.7, pp.2502-2507, 1995. ,
Immune activation of the central nervous system is still present after >4 years of effective highly active antiretroviral therapy, J. Infect. Dis, vol.196, pp.1779-1783, 2007. ,
HIV and antiretroviral therapy in the brain: neuronal injury and repair, Nat. Rev. Neurosci, vol.8, pp.33-44, 2007. ,
Prevalence of Alzheimer plaques in AIDS, J. Neurol. Neurosurg. Psychiatry, vol.65, pp.29-33, 1998. ,
Human immunodeficiency virus infection of human astrocytes disrupts blood-brain barrier integrity by a gap junction-dependent mechanism, J. Neurosci, vol.31, pp.9456-9465, 2011. ,
Increased glutamate in CSF and plasma of patients with HIV dementia, Neurology, vol.57, pp.671-675, 2001. ,
Evidence that the amyloid-? protein precursor intracellular domain, AICD, derives from ?-secretase-generated C-terminal fragment, J. Alzheimers Dis, vol.30, pp.145-153, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00724562
Risk factors for late-onset Alzheimer's disease: a population-based, case-control study, Ann. Neurol, vol.33, pp.258-266, 1993. ,
Caspase cascades in human immunodeficiency virus-associated neurodegeneration, J. Neurosci, vol.22, pp.4015-4024, 2002. ,
Temporal cascade of plasma level surges in ACTH, corticosterone and cytokines in endotoxin-challenged rats, Am. J. Physiol, vol.267, 1994. ,
URL : https://hal.archives-ouvertes.fr/hal-01923650
The neuropathogenesis of AIDS, Nat. Rev. Immunol, vol.5, pp.69-81, 2005. ,
Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury and amyloid ?-peptide toxicity in hippocampal neurons, Curr. Alzheimer Res, vol.66, pp.1015-1033, 1996. ,
Glucocorticoids increase amyloid-? and tau pathology in a mouse model of Alzheimer's disease, J. Neurosci, vol.26, pp.9047-9056, 2006. ,
Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients, AIDS, vol.19, pp.407-411, 2005. ,
Neuroinflammatory TNF? impairs memory via astrocyte signaling, Cell, vol.163, pp.1730-1741, 2015. ,
HIV Tat protein and amyloid-? peptide form multifibrillar structures that cause neurotoxicity, Nat. Struct. Mol. Biol, vol.24, pp.379-386, 2017. ,
HIV-1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity, J. Neurochem, vol.78, pp.457-467, 2001. ,
Occupational exposure to pesticides increases the risk of incident AD: the Cache County study, Neurology, vol.74, pp.1524-1530, 2010. ,
HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors, J. Neurovirol, vol.17, pp.3-16, 2011. ,
CNS reservoirs for HIV: implications for eradication, J. Virus Erad, vol.1, pp.67-71, 2015. ,
Complement and microglia mediate early synapse loss in Alzheimer mouse models, Science, vol.352, pp.712-716, 2016. ,
Pathophysiological role of neuroinflammation in neurodegenerative diseases and psychiatric disorders, Int. Neurourol. J, vol.20, 2016. ,
Increased cerebrospinal fluid cortisol level in Alzheimer's disease is not related to depression, Neurobiol. Aging, vol.27, 2006. ,
Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues, J. Neurovirol, vol.6, pp.145-155, 2000. ,
Herpes simplex virus type 1 and Alzheimer's disease: increasing evidence for a major role of the virus, Front. Aging Neurosci, vol.6, p.202, 2014. ,
Herpes simplex virus type 1 in brain and risk of Alzheimer's disease, Lancet, vol.349, pp.241-244, 1997. ,
Epidemiology of human immunodeficiency virus infection and the neurologic complications of the infection, Semin. Neurol, vol.12, pp.10-17, 1992. ,
, , 2017.
, HIV-1 transactivator protein induces ZO-1 and neprilysin dysfunction in brain endothelial cells via the ras signaling pathway, Oxid. Med. Cell. Longev, p.3160360, 2017.
Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience, Radiology, vol.234, pp.851-859, 2005. ,
Erythropoietin plus insulin-like growth factor-I protects against neuronal damage in a murine model of human immunodeficiency virus-associated neurocognitive disorders, Ann. Neurol, vol.68, pp.342-352, 2010. ,
HIV-1 gp120 compromises blood-brain barrier integrity and enhance monocyte migration across blood-brain barrier: implication for viral neuropathogenesis, J. Cereb. Blood Flow Metab, vol.27, pp.123-134, 2007. ,
Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis, Proc. Natl. Acad. Sci. U S A, vol.96, pp.8212-8216, 1999. ,
Loss of neurons in the frontal cortex in AIDS brains, Acta Neuropathol, vol.80, pp.92-94, 1990. ,
HIV-1 Tat interacts with and regulates the localization and processing of amyloid precursor protein, PLoS One, vol.8, p.77972, 2013. ,
, HIV tat and neurotoxicity. Microbes Infect, vol.8, pp.1347-1357, 2006.
AIDS/HPA axis, 2000. ,
HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload and oxidative stress, Exp. Neurol, vol.154, pp.276-288, 1998. ,
Functional characterization of amyloid ? precursor protein regulatory elements: rationale for the identification of genetic polymorphism, Ann. N Y Acad. Sci, vol.1030, pp.282-288, 2004. ,
The relation between long-term cortisol levels and the metabolic syndrome in HIV-infected patients, Clin. Endocrinol, vol.83, pp.167-172, 2015. ,
Human immunodeficiency virus type 1 and its coat protein gp120 induce apoptosis and activate JNK and ERK mitogen-activated protein kinases in human neurons, Ann. Neurol, vol.42, pp.847-856, 1997. ,
Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1, Proc. Natl. Acad. Sci. U S A, vol.91, pp.10873-10877, 1994. ,
Good neurocognitive performance measured by the international HIV dementia scale in early HIV-1 infection, J. Acquir. Immune Defic. Syndr, vol.52, pp.488-492, 2009. ,
Blood-brain barrier abnormalities caused by exposure to HIV-1 gp120-protection by gene delivery of antioxidant enzymes, Neurobiol. Dis, vol.38, pp.313-325, 2010. ,
Cortisol levels during human aging predict hippocampal atrophy and memory deficits, Nat. Neurosci, vol.1, pp.69-73, 1998. ,
Virological and immunological characteristics of human cytomegalovirus infection associated with Alzheimer disease, J. Infect. Dis, vol.208, pp.564-572, 2013. ,
Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: involvement of glucocorticoid secretion and excitatory amino acid receptors, Neuroscience, vol.69, pp.89-98, 1995. ,
The cerebrospinal fluid biomarker profile in an HIV-infected subject with Alzheimer's disease, AIDS Res. Ther, vol.12, p.23, 2015. ,
Synaptic dysfunction in Alzheimer's disease, Adv. Exp. Med. Biol, vol.970, pp.573-601, 2012. ,
Alzheimer's dementia begins as a disease of small blood vessels, damaged by oxidative-induced inflammation and dysregulated amyloid metabolism: implications for early detection and therapy, FASEB J, vol.25, pp.5-13, 2011. ,
Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART), J. Neurol. Neurosurg. Psychiatry, vol.69, pp.376-380, 2000. ,
Spectrum of human immunodeficiency virus-associated neocortical damage, Ann. Neurol, vol.32, pp.321-329, 1992. ,
Infectious agents and age-related neurodegenerative disorders, Ageing Res. Rev, vol.3, 2004. ,
Human immunodeficiency virus-associated dementia: an evolving disease, J. Neurovirol, vol.9, pp.205-221, 2003. ,
Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort study, Neurology, vol.43, pp.2245-2252, 1993. ,
Human immunodeficiency virus-associated neurocognitive disorders: mind the gap, Ann. Neurol, vol.67, pp.699-714, 2010. ,
Central effects of stress hormones in health and disease: understanding the protective and damaging effects of stress and stress mediators, Eur. J. Pharmacol, vol.583, pp.174-185, 2008. ,
Differentiating HIV-associated neurocognitive disorders from Alzheimer's disease: an emerging issue in geriatric NeuroHIV, Curr. HIV/AIDS Rep, vol.14, pp.123-132, 2017. ,
Human immunodeficiency virus type 1 Tat modulates proliferation and differentiation of human neural precursor cells: implication in NeuroAIDS, J. Neurovirol, vol.16, pp.355-367, 2010. ,
Alzheimer's disease: a matter of blood-brain barrier dysfunction?, J. Exp. Med, vol.214, pp.3151-3169, 2017. ,
Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia, J. Infect. Dis, vol.7609, pp.193-198, 2002. ,
LRP promotes endocytosis and degradation, but not transcytosis, of the amyloid-? peptide in a blood-brain barrier in vitro model, Neurobiol. Dis, vol.30, pp.94-102, 2008. ,
Role of HIV in amyloid metabolism, J. Neuroimmune Pharmacol, vol.9, pp.483-491, 2014. ,
Increased CDK5 expression in HIV encephalitis contributes to neurodegeneration via tau phosphorylation and is reversed with Roscovitine, Am. J. Pathol, vol.178, pp.1646-1661, 2011. ,
Biological analysis of human immunodeficiency virus type 1 R5 envelopes amplified from brain and lymph node tissues of AIDS patients with neuropathology reveals two distinct tropism phenotypes and identifies envelopes in the brain that confer an enhanced tropism and fusigenicity for macrophages, J. Virol, vol.78, pp.6915-6926, 2004. ,
HIV receptors within the brain: a study of CD4 and MHC-II on human neurons, astrocytes and microglial cells, Res. Virol, vol.142, pp.145-149, 1991. ,
New selective glucocorticoid receptor modulators reverse amyloid-? peptide-induced hippocampus toxicity, Neurobiol. Aging, vol.45, pp.109-122, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01923503
Targeting the glutamatergic system for the treatment of HIV-associated neurocognitive disorders, J. Neuroimmune Pharmacol, vol.8, pp.594-607, 2013. ,
World Alzheimer report 2015: the global impact of dementia-an analysis of prevalence, incidence, 2015. ,
Microglia-Mediated synapse loss in Alzheimer's disease, J. Neurosci, vol.38, pp.2911-2919, 2018. ,
Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation, Endocrinology, vol.117, pp.2505-2511, 1985. ,
West nile virus-induced cell adhesion molecules on human brain microvascular endothelial cells regulate leukocyte adhesion and modulate permeability of the in vitro blood-brain barrier model, PLoS One, vol.9, 2014. ,
Glucocorticoids and the regulation of memory consolidation, Psychoneuroendocrinology, vol.25, p.58, 2000. ,
Blood-brain barrier permeability in aging and Alzheimers disease, J. Prev. Alzheimers Dis, vol.1, pp.138-139, 2014. ,
Long-term HIV-1 infection of neural progenitor populations, AIDS, vol.21, pp.2271-2281, 2007. ,
A hitchhiker's guide to the nervous system: the complex journey of viruses and toxins, Nat. Rev. Microbiol, vol.8, pp.645-655, 2010. ,
HIV-1 Nef is released in extracellular vesicles derived from astrocytes: evidence for Nef-mediated neurotoxicity, Cell Death Dis, vol.8, p.2542, 2017. ,
Axonal transport mediates West Nile virus entry into the central nervous system and induces acute flaccid paralysis, Proc. Natl. Acad. Sci. U S A, vol.104, pp.17140-17145, 2007. ,
Alzheimer's disease: genes, proteins and therapy, Physiol. Rev, vol.81, pp.741-766, 2001. ,
Endocrine and metabolic disturbances in human immunodeficiency virus infection and the acquired immune deficiency syndrome, Endocr. Rev, vol.17, pp.518-532, 1996. ,
Herpesviruses use bidirectional fast-axonal transport to spread in sensory neurons, Proc. Natl. Acad. Sci. U S A, vol.98, pp.3466-3470, 2001. ,
Association of antiretroviral therapy with brain aging changes among HIV-infected adults, AIDS, 2018. ,
Stress acts cumulatively to precipitate Alzheimer's disease-like tau pathology and cognitive deficits, J. Neurosci, vol.31, pp.7840-7847, 2011. ,
BACE1 mediates HIV-associated and excitotoxic neuronal damage through an APP-dependent mechanism, J. Neurosci, vol.38, pp.4288-4300, 2018. ,
Endothelial LRP1 transports amyloid-? 1?42 across the bloodbrain barrier, J. Clin. Invest, vol.126, pp.123-136, 2016. ,
Compartmentalized replication of R5 T cell-tropic HIV-1 in the central nervous system early in the course of infection, PLoS Pathog, vol.11, 2015. ,
Corticosterone acutely prolonged N-methyl-daspartate receptor-mediated Ca 2+ elevation in cultured rat hippocampal neurons, J. Neurochem, vol.83, pp.1441-1451, 2002. ,
Global HIV neurology: a comprehensive review, AIDS, 2018. ,
An individual with human immunodeficiency virus, dementia and central nervous system amyloid deposition, Alzheimers Dement, vol.4, pp.1-5, 2016. ,
Tumor necrosis factor inhibits glucocorticoid receptor function in mice: a strong signal toward lethal shock, J. Biol. Chem, vol.286, pp.26555-26567, 2011. ,
A complement-microglial axis drives synapse loss during virus-induced memory impairment, Nature, vol.534, pp.538-543, 2016. ,
Neuronal glycolytic pathway impairment induced by HIV envelope glycoprotein gp120, Mol. Cell. Biochem, vol.215, pp.73-80, 2000. ,
Spatial learning and memory in HIV-1 transgenic rats, J. Neuroimmune Pharmacol, vol.2, pp.319-328, 2007. ,
Glucocorticoids inhibit glucose transport and glutamate uptake in hippocampal astrocytes: implications for glucocorticoid neurotoxicity, J. Neurochem, vol.57, pp.1422-1428, 1991. ,
HIV-1 Vpr disrupts mitochondria axonal transport and accelerates neuronal aging, Neuropharmacology, vol.117, pp.364-375, 2017. ,
Effects of human immunodeficiency virus type 1 on astrocyte gene expression and function: potential role in neuropathogenesis, J. Neurovirol, vol.10, pp.25-32, 2004. ,
Estimates for, 2000. ,
JAM-A and ALCAM are therapeutic targets to inhibit diapedesis across the BBB of CD14 + CD16 + monocytes in HIV-infected individuals, J. Leukoc. Biol, vol.97, pp.401-412, 2015. ,
The comorbidity of HIV-associated neurocognitive disorders and Alzheimer's disease: a foreseeable medical challenge in post-HAART era, J. Neuroimmune Pharmacol, vol.4, pp.200-212, 2009. ,
Blood-brain barrier dysfunction and the pathogenesis of Alzheimer's disease, Int. J. Mol. Sci, vol.18, 1965. ,
Pesticide exposure and risk of Alzheimer's disease: a systematic review and meta-analysis, Sci. Rep, vol.6, p.32222, 2016. ,
, , 2009.
, HIV-1 gp120 induces cytokine expression, leukocyte adhesion and transmigration across the blood-brain barrier: modulatory effects of STAT1 signaling, Microvasc. Res, vol.77, pp.212-219
Glucocorticoids exacerbate the deleterious effects of gp120 in hippocampal and cortical explants, J. Neurochem, vol.74, pp.1000-1007, 2000. ,
HIV-1 matrix protein p17 misfolding forms toxic amyloidogenic assemblies that induce neurocognitive disorders, Sci. Rep, vol.7, p.10313, 2017. ,
Blood-brain barrier and neuro-AIDS, Eur. Rev. Med. Pharmacol. Sci, vol.19, pp.4927-4939, 2015. ,
Establishment and dysfunction of the blood-brain barrier, Cell, vol.163, pp.1064-1078, 2015. ,